Tokyo Tape
Sign in
← Otsuka Holdings

Half-year report · HY

4578.TEDINET S100YTLB
Period2026-01-01 → 2026-06-30
Filed2026-07-31
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥1.33T2026-01-01 → 2026-06-30Cons.Revenue IFRS
Revenue¥2.47T2025-01-01 → 2025-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.18T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Operating income¥278.5bn2026-01-01 → 2026-06-30Cons.Operating profit loss IFRS
Operating income¥242.1bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Profit before tax¥285.4bn2026-01-01 → 2026-06-30Cons.Profit loss before tax IFRS
Profit before tax¥468.0bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥226.3bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥215.6bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥363.1bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥173.5bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥218.5bn2026-01-01 → 2026-06-30Cons.Profit loss IFRS
Net income¥175.9bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Total assets¥4.40Tat 2026-06-30Cons.Assets IFRS
Total assets¥4.20Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.79Tat 2025-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.09Tat 2026-06-30Cons.Liabilities IFRS
Total liabilities¥1.10Tat 2025-12-31Cons.Liabilities IFRS
Net assets / equity¥3.31Tat 2026-06-30Cons.Equity IFRS
Net assets / equity¥3.10Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥2.79Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥2.78Tat 2024-12-31vCons.Equity IFRS
Equity (owners)¥3.24Tat 2026-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.03Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.72Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥469.5bnat 2026-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥534.6bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥411.1bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥426.2bnat 2024-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥217.1bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥403.6bn2025-01-01 → 2025-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥212.7bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥173.0bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥161.6bn2025-01-01 → 2025-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥130.9bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥114.3bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥137.3bn2025-01-01 → 2025-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥85.4bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥409.072026-01-01 → 2026-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥685.062025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥326.122025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
Equity ratio73.7%at 2026-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.3%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.8%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥65.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥63.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30¥6.2bn
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥1.8bn
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥1.8bn
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥28.7bn
Consumer Productsreportable segmentrevenue2026-01-01 → 2026-06-30¥17.5bn
Consumer Productsreportable segmentrevenue external2026-01-01 → 2026-06-30¥17.4bn
Consumer Productsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥15m
Consumer Productsreportable segmentsegment profit2026-01-01 → 2026-06-30¥13.8bn
Nutraceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥300.1bn
Nutraceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥300.1bn
Nutraceuticalsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥16m
Nutraceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥36.8bn
Pharmaceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥951.6bn
Pharmaceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥951.6bn
Pharmaceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥250.4bn
—segment totalrevenue2026-01-01 → 2026-06-30¥1.33T
—segment totalrevenue external2026-01-01 → 2026-06-30¥1.33T
—segment totalrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
—segment totalsegment profit2026-01-01 → 2026-06-30¥307.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥56.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥55.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30¥5.0bn
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥1.7bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥1.7bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥27.8bn
Consumer Productsreportable segmentrevenue2025-01-01 → 2025-06-30¥15.8bn
Consumer Productsreportable segmentrevenue external2025-01-01 → 2025-06-30¥15.8bn
Consumer Productsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥9m
Consumer Productsreportable segmentsegment profit2025-01-01 → 2025-06-30¥12.9bn
Nutraceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥276.1bn
Nutraceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥276.0bn
Nutraceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥19m
Nutraceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥36.7bn
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥833.8bn
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥833.8bn
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥215.4bn
—segment totalrevenue2025-01-01 → 2025-06-30¥1.18T
—segment totalrevenue external2025-01-01 → 2025-06-30¥1.18T
—segment totalrevenue intersegment2025-01-01 → 2025-06-30¥1.7bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥269.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 797
ItemContextValueUnit
Income taxes payable ncl IFRSInterimInstant－JPY
Retirement benefit liability ncl IFRSPrior1YearInstant12574000000JPY
Retirement benefit liability ncl IFRSInterimInstant11052000000JPY
Provisions ncl IFRSPrior1YearInstant3944000000JPY
Provisions ncl IFRSInterimInstant4226000000JPY
Contract liabilities ncl IFRSPrior1YearInstant26025000000JPY
Contract liabilities ncl IFRSInterimInstant22457000000JPY
Deferred tax liabilities IFRSPrior1YearInstant33593000000JPY
Deferred tax liabilities IFRSInterimInstant33561000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant35474000000JPY
Other non current liabilities ncl IFRSInterimInstant44319000000JPY
Non current labilities IFRSPrior1YearInstant348688000000JPY
Non current labilities IFRSInterimInstant350170000000JPY
Liabilities IFRSPrior1YearInstant1097801000000JPY
Liabilities IFRSInterimInstant1089134000000JPY
Share capital IFRSPrior1YearInstant81690000000JPY
Share capital IFRSInterimInstant81690000000JPY
Capital surplus IFRSPrior1YearInstant428044000000JPY
Capital surplus IFRSInterimInstant428243000000JPY
Treasury shares IFRSPrior1YearInstant-85186000000JPY
Treasury shares IFRSInterimInstant-114598000000JPY
Retained earnings IFRSPrior1YearInstant2205740000000JPY
Retained earnings IFRSInterimInstant2386928000000JPY
Other components of equity IFRSPrior1YearInstant403154000000JPY
Other components of equity IFRSInterimInstant457446000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant3033444000000JPY
Equity attributable to owners of parent IFRSInterimInstant3239710000000JPY
Non controlling interests IFRSPrior1YearInstant66317000000JPY
Non controlling interests IFRSInterimInstant67045000000JPY
Equity IFRSPrior1YearInstant3099761000000JPY
Equity IFRSInterimInstant3306756000000JPY
Liabilities and equity IFRSPrior1YearInstant4197562000000JPY
Liabilities and equity IFRSInterimInstant4395890000000JPY
Revenue IFRSPrior1InterimDuration1180766000000JPY
Revenue IFRSInterimDuration1332390000000JPY
Cost of sales IFRSPrior1InterimDuration325425000000JPY
Cost of sales IFRSInterimDuration365909000000JPY
Gross profit IFRSPrior1InterimDuration855341000000JPY
Gross profit IFRSInterimDuration966481000000JPY
Selling general and administrative expenses IFRSPrior1InterimDuration471976000000JPY
Selling general and administrative expenses IFRSInterimDuration533935000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1InterimDuration18760000000JPY
Share of profit loss of investments accounted for using equity method IFRSInterimDuration20207000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1InterimDuration162903000000JPY
Research and development expenditure recognized as expense during period IFRSInterimDuration172174000000JPY
Impairment losses pl IFRSPrior1InterimDuration531000000JPY
Impairment losses pl IFRSInterimDuration4052000000JPY
Other income IFRSPrior1InterimDuration5001000000JPY
Other income IFRSInterimDuration7214000000JPY
Other expenses IFRSPrior1InterimDuration1572000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass